Celsius (CELH) Investors with Losses Encouraged to Contact Hagens Berman Before Jan. 21, 2025 Deadline in Securities Class Action
San Francisco, California--(Newsfile Corp. - January 10, 2025) - Shares of Celsius Holdings (NASDAQ: CELH), the energy drink maker already reeling from a 58 percent year-to-date decline, faced renewed pressure this month after a key analyst lowered its price target, citing concerns about sales and the impact of its distribution agreement with PepsiCo. This diminished valuation adds to the company's woes, which include slowing sales, revised financial forecasts, and a shareholder lawsuit...
2025-01-10 8:54 AM EST
Symbotic (SYM) Restates Financials, Faces Scrutiny Amid Accounting Concerns - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 10, 2025) - Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024 quarters, revealing significant errors in its previously reported revenue and profitability figures. The restatements, filed on December 4, follow the revelation of accounting errors last month and come as the company faces a securities fraud class action lawsuit. Hagens Berman has...
2025-01-10 8:44 AM EST
Symbotic (SYM) Restates Financials, Faces Scrutiny Amid Accounting Concerns - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 3, 2025) - Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024 quarters, revealing significant errors in its previously reported revenue and profitability figures. The restatements, filed on December 4, follow the revelation of accounting errors last month and come as the company faces a securities fraud class action lawsuit. Hagens Berman has...
2025-01-03 9:12 AM EST
ASP Isotopes (ASPI) Continue to Slump Despite Response to Short Seller Report - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 3, 2025) - Shares of ASP Isotopes Inc. (NASDAQ: ASPI) have continue their downward spiral falling 16% over the past five days, despite the company having issued a rebuttal to a scathing report from activist short-seller Fuzzy Panda Research. The stock price trades at $4.52 per share, marking a 40% decline since the release of the short seller report late last month. The Fuzzy Panda report, published on November 26, accused ASP Isotopes of...
2025-01-03 9:10 AM EST
Analyst Downgrade Fuels Further Decline for Celsius (CELH) Shares Amid Sales Concerns and Investor Lawsuit- Hagens Berman
San Francisco, California--(Newsfile Corp. - January 3, 2025) - Shares of Celsius Holdings (NASDAQ: CELH), the energy drink maker already reeling from a 58 percent year-to-date decline, faced renewed pressure this month after a key analyst lowered its price target, citing concerns about sales and the impact of its distribution agreement with PepsiCo. This diminished valuation adds to the company's woes, which include slowing sales, revised financial forecasts, and a shareholder lawsuit...
2025-01-03 9:08 AM EST
Medicare Fraud Allegations Cast Shadow Over PACS Group (PACS) - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 3, 2025) - PACS Group (NYSE: PACS), a nursing home operator that saw its stock soar after its initial public offering in April, has experienced a precipitous decline in recent weeks, losing 70 percent of its market capitalization since early November. The company is now grappling with allegations of deceptive Medicare billing practices, a federal regulatory investigation, delayed financial reporting and a burgeoning investor class-action...
2025-01-03 9:06 AM EST
AstraZeneca (AZN) Reels from China Investigation and Investor Suit- Hagens Berman
San Francisco, California--(Newsfile Corp. - January 2, 2025) - AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a series of unsettling reports emanating from China. A widening investigation by China regulators into alleged illegal drug imports, data breaches, and potential health insurance fraud has cast a shadow over the company's prospects in a critical market, triggering a securities class...
2025-01-02 12:48 PM EST
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 1, 2025) - On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling announcement that it was discontinuing a Phase 2 study for its lead product, azelaprag, intended to treat metabolic diseases such as obesity. Hagens Berman has opened an investigation and urges investors in BioAge who purchased shares in the company's IPO or on the open market and...
2025-01-01 10:00 AM EST
Sezzle Inc. (SEZL) Shares Crash After Hindenburg Alleges Risky Practices - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 1, 2025) - Sezzle Inc. (NASDAQ: SEZL), a buy now, pay later (BNPL) company, lost nearly a quarter of its market capitalization on December 18th following a damning report released by activist short seller Hindenburg Research, alleging that Sezzle has engaged in risky lending practices. Shareholder rights firm Hagens Berman has opened an investigation into the allegations to determine whether Sezzle may have violated the U.S. securities laws...
2025-01-01 10:00 AM EST
Fluence Energy (FLNC) Posts Declining Revenues Amid SEC Investigation - Hagens Berman
San Francisco, California--(Newsfile Corp. - January 1, 2025) - Shares of electricity storage and software provider Fluence Energy (NASDAQ: FLNC) are down more than 28% year-to-date as the company continues to post declining revenue growth amid an SEC investigation into the company's alleged improper accounting practices. Hagens Berman is investigating whether Fluence Energy may have violated the U.S. securities laws and urges investors who suffered substantial losses to submit your losses...
2025-01-01 10:00 AM EST
Symbotic (SYM) Restates Financial Results Amid Securities Class Action Over Improper Accounting - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 31, 2024) - Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024 quarters, revealing significant errors in its previously reported revenue and profitability figures. The restatements, filed on December 4, follow the revelation of accounting errors last month and come as the company faces a securities fraud class action lawsuit. Hagens Berman has...
2024-12-31 1:21 PM EST
Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 31, 2024) - PACS Group, Inc. (NYSE: PACS) and certain of its C-Suite officers are now entangled in a securities class action lawsuit, following allegations of misleading investors by engaging in deceptive Medicare practices. Hagens Berman urges investors in PACS Group who suffered substantial losses to submit your losses now. Class Period: Apr. 11, 2024 - Nov. 5, 2024 Lead Plaintiff Deadline: Jan. 13, 2025 Visit:...
2024-12-31 1:17 PM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 31, 2024) - Shares of Celsius Holdings (NASDAQ: CELH), the energy drink maker already reeling from a 58 percent year-to-date decline, faced renewed pressure this month after a key analyst lowered its price target, citing concerns about sales and the impact of its distribution agreement with PepsiCo. This diminished valuation adds to the company's woes, which include slowing sales, revised financial forecasts, and a shareholder lawsuit...
2024-12-31 1:14 PM EST
ASP Isotopes (ASPI) Continue to Slump Despite Response to Short Seller Report - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 31, 2024) - Shares of ASP Isotopes Inc. (NASDAQ: ASPI) have continue their downward spiral falling 16% over the past five days, despite the company having issued a rebuttal to a scathing report from activist short-seller Fuzzy Panda Research. The stock price trades at $4.52 per share, marking a 40% decline since the release of the short seller report late last month. The Fuzzy Panda report, published on November 26, accused ASP Isotopes of...
2024-12-31 1:03 PM EST
AstraZeneca (AZN) Reels from China Investigation and Investor Suit- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 30, 2024) - AstraZeneca, the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a series of unsettling reports emanating from China. A widening investigation by China regulators into alleged illegal drug imports, data breaches, and potential health insurance fraud has cast a shadow over the company's prospects in a critical market, triggering a securities class action...
2024-12-30 5:15 PM EST
Symbotic (SYM) Restates Financials, Faces Scrutiny Amid Accounting Concerns - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 26, 2024) - SAN FRANCISCO – Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024 quarters, revealing significant errors in its previously reported revenue and profitability figures. The restatements, filed on December 4, follow the revelation of accounting errors last month and come as the company faces a securities fraud class action lawsuit....
2024-12-26 2:47 PM EST
ASP Isotopes (ASPI) Accused of Deceiving Investors with Bogus Nuclear Tech Claims- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 25, 2024) - ASP Isotopes Inc. (NASDAQ: ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now. Class Period: Oct. 30, 2024 - Nov. 26, 2024 Lead Plaintiff Deadline: Feb....
2024-12-25 12:05 PM EST
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 25, 2024) - On December 9, 2024, just months after conducting an initial public offering in September 2024, BioAge Labs, Inc. (NASDAQ: BIOA) made the startling announcement that it was discontinuing a Phase 2 study for its lead product, azelaprag, intended to treat metabolic diseases such as obesity. Hagens Berman has opened an investigation and urges investors in BioAge who purchased shares in the company's IPO or on the open market and...
2024-12-25 12:04 PM EST
AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption - Hagens Berman
San Francisco, California--(Newsfile Corp. - December 25, 2024) - AstraZeneca, the British-Swedish pharmaceutical giant, is facing a securities class action lawsuit in the U.S. alleging the company misled investors about its business practices in China, a critical market that accounts for roughly 13% of its revenue. Hagens Berman has opened an investigation and urges investors in AstraZeneca American Depositary Shares who suffered substantial losses to submit your losses now. Class Period:...
2024-12-25 12:03 PM EST
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi- Hagens Berman
San Francisco, California--(Newsfile Corp. - December 25, 2024) - Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its C-Suite officers are embroiled in a securities class action lawsuit, claiming they misrepresented and concealed crucial information about the company's financial performance, especially concerning its key customer, PepsiCo. Hagens Berman is investigating the allegations and urges investors in Celsius who purchased shares and suffered substantial losses to submit your...
2024-12-25 12:02 PM EST